Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4678)
All Articles published online
|
Jan 14, 2010 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi M, Chen JA, Lin XJ, Guo RP, Yuan YF, Chen MS, Zhang YQ, Li JQ. Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China. World J Gastroenterol 2010; 16(2): 264-269 [PMID: 20066748 DOI: 10.3748/wjg.v16.i2.264] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/264.htm |
| Number | Citing Articles |
| 1 |
Zhi-Liang Huang, Jun Luo, Min-Shan Chen, Jin-Qing Li, Ming Shi. Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology 2011; 22(5): 702 doi: 10.1016/j.jvir.2010.12.041
|
| 2 |
Bruno Sangro, Delia D'Avola, Mercedes Iñarrairaegui, Jesus Prieto. Transarterial therapies for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2011; 12(7): 1057 doi: 10.1517/14656566.2011.545346
|
| 3 |
Wei Wei, Pei‐En Jian, Shao‐Hua Li, Zhi‐Xing Guo, Yong‐Fa Zhang, Yi‐Hong Ling, Xiao‐Jun Lin, Li Xu, Ming Shi, Lie Zheng, Min‐Shan Chen, Rong‐Ping Guo. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Cancer Communications 2018; 38(1): 1 doi: 10.1186/s40880-018-0331-y
|
| 4 |
Natsuhiko Saito, Toshihiro Tanaka, Hideyuki Nishiohuku, Takeshi Sato, Tetsuya Masada, Takeshi Matsumoto, Hiroshi Anai, Hiroshi Sakaguchi, Satoru Sueyoshi, Nagaaki Marugami, Kimihiko Kichikawa. Transarterial‐ chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver function. Hepatology Research 2020; 50(10): 1176 doi: 10.1111/hepr.13550
|
| 5 |
QIANG-SHENG DAI, HONG-LIN GU, SHENG YE, YAO-JUN ZHANG, XIAO-JUN LIN, WAN YEE LAU, ZHEN-WEI PENG, MIN-SHAN CHEN. Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Molecular and Clinical Oncology 2014; 2(6): 1047 doi: 10.3892/mco.2014.391
|
| 6 |
Wenzhe Fan, Yingqiang Zhang, Yu Wang, Xuehua Yao, Jianyong Yang, Jiaping Li, Seung Up Kim. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization. PLOS ONE 2015; 10(3): e0119312 doi: 10.1371/journal.pone.0119312
|
| 7 |
Mohamed A S Kohla, Mai I Abu Zeid, Mohamed Al-Warraky, Hossam Taha, Robert G Gish. Predictors of hepatic decompensation after TACE for hepatocellular carcinoma. BMJ Open Gastroenterology 2015; 2(1): e000032 doi: 10.1136/bmjgast-2015-000032
|
| 8 |
Katrin Eichler, Stephan Zangos, Tatjana Gruber-Rouh, Thomas J. Vogl, Martin G. Mack. Magnetic Resonance-guided Laser-induced Thermotherapy in Patients With Oligonodular Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2012; 46(9): 796 doi: 10.1097/MCG.0b013e3182641806
|
| 9 |
Ahmed Abdelmabood Zeeneldin, Salem Eid Salem, Reda Hassan Tabashy, Asmaa Ahmed Ibrahim, Nelly Hassan Alieldin. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: A single center experience including 221 patients. Journal of the Egyptian National Cancer Institute 2013; 25(3): 143 doi: 10.1016/j.jnci.2013.05.003
|
| 10 |
Beili Wang, Feng Li, Luya Cheng, Yanxia Zhan, Boting Wu, Pu Chen, Junfei Shen, Wenhao Wu, Xiaolu Ma, Jie Zhu, Baishen Pan, Wei Guo, Yunfeng Cheng. The Pretreatment Platelet Count is an Independent Predictor of Tumor Progression in Patients Undergoing Transcatheter Arterial Chemoembolization with Hepatitis B Virus-Related Hepatocellular Carcinoma. Future Oncology 2019; 15(8): 827 doi: 10.2217/fon-2018-0591
|
| 11 |
Joong‐Won Park, Deepak Amarapurkar, Yee Chao, Pei‐Jer Chen, Jean‐Francois H. Geschwind, Khean Lee Goh, Kwang‐Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun‐Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T Poon, Chee‐Kiat Tan, Tawesak Tanwandee, Gaojun Teng, Ann‐Lii Cheng. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver International 2013; 33(3): 327 doi: 10.1111/liv.12083
|
| 12 |
J. Luo, M. Shi. Response. JNCI Journal of the National Cancer Institute 2013; 105(8): 580 doi: 10.1093/jnci/djt046
|
| 13 |
Zhong-Guo Zhou, Xing-Rong Zheng, Qian Zhou, Ming Shi, Yao-Jun Zhang, Rong-Ping Guo, Yun-Fei Yuan, Min-Shan Chen, Xiao-Jun Lin, Xiang-Ming Lao, Sheng-Ping Li. Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization. Chinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0017-7
|
| 14 |
Jun Luo, Rong-Ping Guo, Eric C. H. Lai, Yao-Jun Zhang, Wan Yee Lau, Min-Shan Chen, Ming Shi. Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study. Annals of Surgical Oncology 2011; 18(2): 413 doi: 10.1245/s10434-010-1321-8
|
| 15 |
Jun-Hui Sun, Tanyang Zhou, Tongyin Zhu, Yuelin Zhang, Chunhui Nie, Jing Ai, Guanhui Zhou, Aibin Zhang, Meng-Jie Dong, Wei-Lin Wang, Shu-Sen Zheng. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3048261
|
| 16 |
Min-Ke He, Ru-Hai Zou, Wei Wei, Jing-Xian Shen, Ming Zhao, Yong-Fa Zhang, Xiao-Jun Lin, Yao-Jun Zhang, Rong-Ping Guo, Ming Shi. Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial. Journal of Vascular and Interventional Radiology 2018; 29(8): 1068 doi: 10.1016/j.jvir.2018.03.027
|
| 17 |
Yong Le, Anna Kan, Qi-Jiong Li, Min-Ke He, Hai-Long Chen, Ming Shi. NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0949-0
|
| 18 |
Lin‐Feng Xu, Hong‐Liang Sun, Yao‐Ting Chen, Jia‐Yan Ni, Dong Chen, Jiang‐Hong Luo, Jing‐Xing Zhou, Ren‐Mei Hu, Qi‐Yun Tan. Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization‐percutaneous microwave coagulation therapy. Journal of Gastroenterology and Hepatology 2013; 28(3): 456 doi: 10.1111/jgh.12088
|
| 19 |
Mostafa M. Shakweer, Abdelshafy A. Awad Allah, Abdel-Aziz K. Aun. Common interventional techniques (single versus combined) in management of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(4): 1407 doi: 10.1016/j.ejrnm.2016.07.001
|
| 20 |
Zhi-Jie Niu, Yi-Long Ma, Ping Kang, Sheng-Qiu Ou, Zhi-Bin Meng, Zhi-Kun Li, Feng Qi, Chang Zhao. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Medical Oncology 2012; 29(4): 2992 doi: 10.1007/s12032-011-0145-0
|
| 21 |
Shashi B. Paul, Hanish Sharma. Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2014; 4: S112 doi: 10.1016/j.jceh.2014.03.048
|
| 22 |
Xiang‐Ming Lao, Guangyu Luo, Liang‐Tao Ye, Cheng Luo, Ming Shi, Dian Wang, Rongping Guo, Minshan Chen, Shengping Li, Xiaojun Lin, Yunfei Yuan. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. Liver International 2013; 33(4): 595 doi: 10.1111/liv.12112
|
| 23 |
Yao Liu, Yuxin Li, Fangyuan Gao, Qun Zhang, Xue Yang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Wei Li, Xianbo Wang. Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Study. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/1341863
|
| 24 |
Wei Cui, Wenzhe Fan, Qun Zhang, Jia Wen, Yonghui Huang, Jianyong Yang, Jiaping Li, Yu Wang. Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin. Oncotarget 2017; 8(45): 79165 doi: 10.18632/oncotarget.16298
|
| 25 |
Xiang‐Ming Lao, Dian Wang, Ming Shi, Guipeng Liu, Shengping Li, Rongping Guo, Yunfei Yuan, Minshan Chen, Jinqing Li, Yaqi Zhang, Xiaojun Lin. Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatology Research 2011; 41(6): 553 doi: 10.1111/j.1872-034X.2011.00796.x
|
| 26 |
Zhen-Wei Peng, Yao-Jun Zhang, Hui-Hong Liang, Xiao-Jun Lin, Rong-Ping Guo, Min-Shan Chen. Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial. Radiology 2012; 262(2): 689 doi: 10.1148/radiol.11110637
|
| 27 |
Yuhua Wen, Lianghe Lu, Jie Mei, Yihong Ling, Renguo Guan, Wenping Lin, Wei Wei, Rongping Guo. Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma 2024; : 665 doi: 10.2147/JHC.S453250
|
| 28 |
Jing‐Houng Wang, Kwong‐Ming Kee, Chih‐Yun Lin, Chao‐Hung Hung, Chien‐Hung Chen, Chuan‐Mo Lee, Sheng‐Nan Lu. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2015; 30(2): 358 doi: 10.1111/jgh.12686
|
| 29 |
Tong-Chun Xue, Qing-An Jia, Ning-Ling Ge, Bo-Heng Zhang, Yan-Hong Wang, Zheng-Gang Ren, Sheng-Long Ye. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization. Tumor Biology 2015; 36(8): 6045 doi: 10.1007/s13277-015-3281-x
|
| 30 |
Yeonjung Ha, Seungbong Han, Ju Hyun Shim, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Han Chu Lee. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2015; 26(8): 1093 doi: 10.1016/j.jvir.2015.04.010
|
| 31 |
Xiaokai Yan, Yao Qi, Xinyue Yao, Lulu Yin, Hao Wang, Ji Fu, Guo Wan, Yanqun Gao, Nanjing Zhou, Xinxin Ye, Xiao Liu, Xing Chen. N6-methyladenosine regulators in hepatocellular carcinoma: investigating the precise definition and clinical applications of biomarkers. Biology Direct 2024; 19(1) doi: 10.1186/s13062-024-00554-2
|
| 32 |
Baogen Zhang, Biqing Huang, Fan Yang, Jiandong Yang, Man Kong, Jing Wang, Yaoxian Xiang, Kangjie Wang, Ruchen Peng, Kun Yang, Chao An, Dong Yan. High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 2024; : 651 doi: 10.2147/JHC.S455953
|
| 33 |
Ming Shi, Li-Gong Lu, Wan-Qiang Fang, Rong-Ping Guo, Min-Shan Chen, Yong Li, Jun Luo, Li Xu, Ru-Hai Zou, Xiao-Jun Lin, Ya-Qi Zhang. Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial. JNCI: Journal of the National Cancer Institute 2013; 105(1): 59 doi: 10.1093/jnci/djs464
|
| 34 |
Jun Luo, Zhen-Wei Peng, Rong-Ping Guo, Ya-Qi Zhang, Jin-Qing Li, Min-Shan Chen, Ming Shi. Hepatic Resection versus Transarterial Lipiodol Chemoembolization as the Initial Treatment for Large, Multiple, and Resectable Hepatocellular Carcinomas: A Prospective Nonrandomized Analysis. Radiology 2011; 259(1): 286 doi: 10.1148/radiol.10101072
|
| 35 |
Qi-Bo Wang, Bo-Kang Cui, Jian-Ming Weng, Qiu-Liang Wu, Ji-Liang Qiu, Xiao-Jun Lin. Clinicopathological Characteristics and Outcome of Primary Sarcomatoid Carcinoma and Carcinosarcoma of the Liver. Journal of Gastrointestinal Surgery 2012; 16(9): 1715 doi: 10.1007/s11605-012-1946-y
|
| 36 |
Tao Zhang, Yong Zeng, Jiwei Huang, Mingheng Liao, Hong Wu. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience. Journal of Surgical Research 2014; 191(2): 370 doi: 10.1016/j.jss.2014.03.048
|
| 37 |
Zhen-Xin Chen, Zhi-Wei Jian, Xi-Wen Wu, Jun-Cheng Wang, Jing-Yuan Peng, Chun-Yu Huang, Xiang-Ming Lao. Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization. Gastroenterology Report 2020; 8(2): 125 doi: 10.1093/gastro/goz040
|
| 38 |
Zhen‐Xin Chen, Zhi‐Wei Jian, Xi‐Wen Wu, Jun‐Cheng Wang, Jing‐Yuan Peng, Xiang‐Ming Lao. Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization. Cancer Medicine 2019; 8(11): 5097 doi: 10.1002/cam4.2380
|